Florida Cancer Specialists & Research Institute leaders present specialty pharmacy operations, dispensing and patient navigation best practices at the NCODA 2026 Spring Forum, highlighting innovations that improve access, patient experience and clinical outcomes in oncology care.
Learn what benign conditions are, including noncancerous growths and inflammatory changes, how they differ from cancer, and when monitoring or treatment may be needed.
Ultra-processed foods: villain or misunderstood? Nutrition expert Nadine Pazder explores the facts behind UPF and provides guidance on how to make informed food choices for a healthier lifestyle.
Learn the truth about sugar and cancer. Discover evidence-based nutrition guidelines and why eliminating all sugar isn’t necessary for cancer patients.
Wherever you live, it’s important to have a disaster preparedness plan. It’s especially important in Florida, where hurricane season is officially June 1 to November 30.
FCS Highlights Leadership in Advancing Medically Integrated Oncology CareFlorida Cancer Specialists & Research Institute leaders present specialty pharmacy operations, dispensing and patient navigation best practices at the NCODA 2026 Spring Forum, highlighting innovations that improve access, patient experience and clinical outcomes in oncology care.
FCS Contributes to Milestone that Expands Treatment Options For Patients With Recurrent Ovarian CancerFDA approves KEYTRUDA for certain hard-to-treat ovarian cancers, with research support from FCS improving outcomes.
FCS Joins Oncology Leaders to Help Shape the Future of Cancer Care at FLASCO 2026FCS joins oncology leaders at FLASCO 2026 to share insights on workforce transformation and innovative care models shaping the future of cancer care.
FCS Phase 3 Trial Demonstrates Initial Clinical Benefit of Novel Immunotherapy For Advanced Non-Small Cell Lung CancerFCS contributes to PRESERVE-003 findings showing gotistobart may improve outcomes in metastatic NSCLC.
FCS Contributes to Phase 1 Study Demonstrating Antitumor Activity with First-in-Class KRAS-Targeted Therapy for Treatment of Lung and Pancreatic CancersFCS participates in study for a targeted therapy for the treatment of two cancers
FCS Welcomes Nikita Jain, MD to PracticeFlorida Cancer Specialists & Research Institute welcomes Nikita Jain, MD, to the team.
Benign Conditions – Summary, Symptoms, TreatmentsLearn what benign conditions are, including noncancerous growths and inflammatory changes, how they differ from cancer, and when monitoring or treatment may be needed.
FCS Expands Team of Cancer Experts in Lee CountyFlorida Cancer Specialists & Research Institute welcomes Xin Yao, MD to Collier County.
